Author

M. Takayama

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

H. Kamada· 1 shared H. Konishi· 1 shared K. Fukao· 1 shared K. Furukawa· 1 shared M. Sato· 1 shared S. Nagata· 1 shared S. Shano· 1 shared T. Hashimoto· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

H. Kamada

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Discovery of anti-SARS-CoV-2 S2 protein antibody CV804 with broad-spectrum reactivity with various beta coronaviruses and analysis of its pharmacological properties in vitro and in vivo

Y. Tsugawa, K. Furukawa, T. Ise, M. Takayama, T. Ota, T. Kuroda, S. Shano, T. Hashimoto, H. Konishi, T. Ishihara, M. Sato, H. Kamada, K. Fukao, T. Shishido, T. Takahashi, S. Nagata

This study identifies an antibody, CV804, that targets the conserved S2 domain of coronaviruses and shows broad cross-reactivity and ADCC activity against SARS-CoV-2 and related viruses.

bioRxiv · Feb 28, 2024Microbiology